These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33886161)

  • 1. The impact of donor-specific anti-human leukocyte antigen antibodies in salvage haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide in patients with nonmalignant disorders.
    Lima ACM; Bonfim C; Getz J; Dornelles LN; do Amaral GB; Petterle RR; Loth G; Nabhan SK; Pereira NF; Pasquini R
    HLA; 2021 Jun; 97(6):493-504. PubMed ID: 33886161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untreated Donor-Specific HLA Antibodies Are Associated With Graft Failure and Poor Survival After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Pediatric Patients With Nonmalignant Disorders.
    Lima ACM; Bonfim C; Getz J; do Amaral GB; Petterle RR; Loth G; Nabhan SK; de Marco R; Gerbase-DeLima M; Pereira NF; Pasquini R
    Transplant Cell Ther; 2022 Oct; 28(10):698.e1-698.e11. PubMed ID: 35882362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy.
    Bailén R; Alenda R; Herruzo-Delgado B; Acosta-Fleitas C; Vallés A; Esquirol A; Fonseca M; Solán L; Sánchez-Vadillo I; Bautista G; Bento L; López-Godino O; Pérez-Martínez A; Torrent A; Zanabili J; Calbacho M; Moreno MÁ; Pascual-Cascón MJ; Guerra-Domínguez L; Chinea A; García-Cadenas I; López-Corral L; Boix-Giner F; López Lorenzo JL; Humala K; Duarte R; Sampol A; Heras I; Vicario JL; Balas A; Oarbeascoa G; Fernández-Caldas P; Anguita J; Kwon M
    Front Immunol; 2023; 14():1165759. PubMed ID: 37304258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-Specific HLA Antibodies Are Associated with Graft Failure and Delayed Hematologic Recovery after Unrelated Donor Hematopoietic Cell Transplantation.
    Lima ACM; Getz J; do Amaral GB; Loth G; Funke VAM; Nabhan SK; Petterle RR; de Marco R; Gerbase-DeLima M; Pereira NF; Bonfim C; Pasquini R
    Transplant Cell Ther; 2023 Aug; 29(8):493.e1-493.e10. PubMed ID: 37220839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets.
    Chang YJ; Zhao XY; Xu LP; Zhang XH; Wang Y; Han W; Chen H; Wang FR; Mo XD; Zhang YY; Huo MR; Zhao XS; Y K; Liu KY; Huang XJ
    J Hematol Oncol; 2015 Jul; 8():84. PubMed ID: 26156584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes.
    Bramanti S; Calafiore V; Longhi E; Mariotti J; Crespiatico L; Sarina B; De Philippis C; Nocco A; Santoro A; Castagna L
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1395-1406. PubMed ID: 30826463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant.
    Bailén R; Vicario JL; Solán L; Sánchez-Vadillo I; Herrera P; Calbacho M; Alenda R; López-Lorenzo JL; Humala K; Chinea A; Sánchez-Pina J; Balas A; Moreno MÁ; Arzuaga J; Pradillo V; Dorado N; Oarbeascoa G; Anguita J; Díez-Martín JL; Kwon M
    Front Immunol; 2021; 12():674658. PubMed ID: 34093576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of immunosuppression intensified conditioning regimen for patients with strong positive pre-transplantation donor-specific anti-HLA antibodies (DSAs) undergoing haploidentical hematopoietic stem cell transplantation].
    Liu HX; Wei DL; Shao S; Jiang Y; Li S; Zhu J; Wang C; Zhao CX
    Zhonghua Xue Ye Xue Za Zhi; 2023 Aug; 44(8):654-659. PubMed ID: 37803839
    [No Abstract]   [Full Text] [Related]  

  • 9. [Allogeneic hematopoietic stem cell transplantation using posttransplant cyclophosphamide].
    Sugita J
    Rinsho Ketsueki; 2020; 61(9):1402-1410. PubMed ID: 33162542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of salvage haploidentical transplantation using posttransplant cyclophosphamide for graft failure following allogeneic hematopoietic stem cell transplantation.
    Harada K; Najima Y; Kato M; Fuji S; Shinohara A; Nakamae H; Toyosaki M; Ashiarai M; Onizuka M; Hashii Y; Ichinohe T; Atsuta Y; Nakasone H
    Int J Hematol; 2022 Nov; 116(5):744-753. PubMed ID: 35767142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Hla Donor-Specific Antibodies Are Associated to Infection and Not to the Engraftment Rate in Outpatient Haploidentical Hematopoietic Cell Transplantation.
    Jaime-Pérez JC; Cruz MLR; Mendoza-Ibarra SI; Moncada-Saucedo NK; Gómez-Almaguer D
    Rev Invest Clin; 2023; 75(5):249-258. PubMed ID: 37918011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HLA-haploidentical stem cell transplantation].
    Sugita J
    Rinsho Ketsueki; 2023; 64(6):515-523. PubMed ID: 37407477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplant With Posttransplant Cyclophosphamide for Graft Failure in a Patient With Chronic Active Epstein-Barr Virus Infection.
    Nakaya Y; Koh H; Harada N; Okamura H; Misugi T; Suekane T; Tachibana D; Kimura H; Hino M; Nakamae H
    Exp Clin Transplant; 2023 Feb; 21(2):184-188. PubMed ID: 36919727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second haploidentical stem cell transplantation for primary graft failure.
    Giammarco S; Raiola AM; Di Grazia C; Bregante S; Gualandi F; Varaldo R; Chiusolo P; Sora F; Sica S; Laurenti L; Metafuni E; Innocenti I; Autore F; Murgia B; Bacigalupo A; Angelucci E
    Bone Marrow Transplant; 2021 Jun; 56(6):1291-1296. PubMed ID: 33328569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.
    Gaballa S; Ge I; El Fakih R; Brammer JE; Kongtim P; Tomuleasa C; Wang SA; Lee D; Petropoulos D; Cao K; Rondon G; Chen J; Hammerstrom A; Lombardi L; Alatrash G; Korbling M; Oran B; Kebriaei P; Ahmed S; Shah N; Rezvani K; Marin D; Bashir Q; Alousi A; Nieto Y; Qazilbash M; Hosing C; Popat U; Shpall EJ; Khouri I; Champlin RE; Ciurea SO
    Cancer; 2016 Nov; 122(21):3316-3326. PubMed ID: 27404668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.
    Ciurea SO; Thall PF; Milton DR; Barnes TH; Kongtim P; Carmazzi Y; López AA; Yap DY; Popat U; Rondon G; Lichtiger B; Aung F; Afshar-Kharghan V; Ma Q; Fernández-Viña M; Champlin RE; Cao K
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1392-8. PubMed ID: 25985919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation].
    Zhang RL; Zheng XH; Zhou LK; Zhang Y; Chen SL; Yang DL; Jiang EL; Wei JL; Huang Y; Ma QL; Zhai WH; Feng SZ; Han MZ; He Y
    Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):190-195. PubMed ID: 29562462
    [No Abstract]   [Full Text] [Related]  

  • 18. Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML.
    Kwon M; Bautista G; Balsalobre P; Sánchez-Ortega I; Montesinos P; Bermúdez A; de Laiglesia A; Herrera P; Martin C; Humala K; Zabalza A; Torres M; Bento L; Corral LL; Heras I; Serrano D; Buño I; Anguita J; Regidor C; Duarte R; Cabrera R; Gayoso J; Diez-Martin JL
    Bone Marrow Transplant; 2017 Aug; 52(8):1138-1143. PubMed ID: 28346415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia.
    Arcuri LJ; Nabhan SK; Cunha R; Nichele S; Ribeiro AAF; Fernandes JF; Daudt LE; Rodrigues ALM; Arrais-Rodrigues C; Seber A; Atta EH; de Oliveira JSR; Funke VAM; Loth G; Junior LGD; Paz A; Calixto RF; Gomes AA; Araujo CES; Colturato V; Simoes BP; Hamerschlak N; Flowers ME; Pasquini R; Rocha V; Bonfim C
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2311-2317. PubMed ID: 32949751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-haploidentical stem cell transplantation using posttransplant cyclophosphamide.
    Sugita J
    Int J Hematol; 2019 Jul; 110(1):30-38. PubMed ID: 31104211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.